Soni, M., Brooker, R., Brammer, C., Ali, Z., Lampkin, I. (2026). The impact of introducing cemiplimab as adjuvant treatment in high-risk cutaneous squamous cell carcinoma on NHS services and facilities.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e18031